Q2 2022 Holdings
Filed 2022-08-10 | 22 holdings | $85.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $44.4M | 1,260,869 | 52.2% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $21.0M | 3,495,575 | 24.7% |
| Cue Health, Inc.(HLTHQ) | COM | 229790100 | $17.8M | 5,548,864 | 20.9% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $1.6M | 394,834 | 1.9% |
| Legend Biotech Corporation(LEGN) | ADS | 52490G102 | $89.6K | 1,629,173 | 0.1% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $83.7K | 3,379,064 | 0.1% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $33.3K | 1,018,478 | 0.0% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $21.9K | 2,898,550 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $20.5K | 748,062 | 0.0% |
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $19.4K | 2,449,183 | 0.0% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $10.6K | 728,944 | 0.0% |
| Fusion Pharmaceuticals Inc. | COM | 36118A100 | $9.1K | 3,670,516 | 0.0% |
| Point Biopharma Global Inc. | COM | 730541109 | $6.8K | 1,000,000 | 0.0% |
| Vor Biopharma, Inc. | COM | 929033108 | $5.3K | 1,074,658 | 0.0% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $2.2K | 192,429 | 0.0% |
| BiomX Inc. | COM | 09090D103 | $1.6K | 2,133,402 | 0.0% |
| SomaLogic, Inc.(SLGCUSD) | COM | 83444K105 | $1.3K | 281,052 | 0.0% |
| PhaseBio Pharmaceuticals, Inc. | COM | 717224109 | $964 | 1,607,044 | 0.0% |
| Tracon Pharmaceuticals, Inc. | COM | 89237H209 | $168 | 84,003 | 0.0% |
| Catalyst Biosciences, Inc. | COM | 14888D208 | $119 | 66,951 | 0.0% |
| Senseonics Holdings, Inc.(SENS1GBP) | COM | 81727U105 | $56 | 54,621 | 0.0% |
| Graybug Vision, Inc. | COM | 38942Q103 | $54 | 49,547 | 0.0% |